Health
BioMérieux SARS-CoV-2 Serology Tests Granted FDA Emergency Use Authorization – HospiMedica
BioMérieux’s (Marcy-l’Étoile, France) has been granted Emergency Use Authorizations (EUAs) by the US Food and Drug Administration (FDA) for two SARS-CoV-2 serology tests.
BioMérieuxs (Marcy-l’Étoile, France) has been granted Emergency Use Authorizations (EUAs) by the US Food and Drug Administration (FDA) for two SARS-CoV-2 serology tests.The FDA has granted EUA to BioMérieuxs VIDAS SARS-COV-2 IgM and VIDAS SARS-COV-2 IgG automated qualitative assays which rapidly detect antibodies to help identify individuals with previous exposure to SARS-CoV-2. With the same protocols to differentiate IgM and IgG results, the VIDAS SARS-COV-2 IgM detects IgM specific for SARS-C…
-
General8 hours agoAustralian celebrity chef Peter Russell-Clarke dies aged 89
-
General22 hours agoWest Indies vs Australia live: Second Test, day three from Grenada
-
General22 hours agoDr Daniel Hunt, Michael Long and Christine Anu celebrated at 50th NAIDOC Week Awards
-
Noosa News17 hours agoRainbow Beach surfer’s untold 7/7 story